Immunotherapy Looks Promising as 1st and 2nd Line Treatment for Advanced Bladder Cancer
News
Immunotherapy agents that block the PD-L1/PD-1 immune checkpoint appears promising as first and second line therapies for metastatic bladder cancer patients who are not eligible or progressed despite first-line platinum-based chemotherapy. ... Read more